Alzheimer’s disease, a devastating neurodegenerative condition that affects millions of people worldwide, may have found a glimmer of hope in an unexpected place – statins. A groundbreaking study led by Karolinska Institutet, recently published in Alzheimer Research and Therapy, suggests that statins, commonly used to lower cholesterol levels, might slow the progression of Alzheimer’s in certain patients. While the results are promising, the researchers emphasize caution, viewing this study as just the first step in the journey of discovery. Statins and Alzheimer’s disease The study’s findings…